Key Highlights
● CLX closed at $83.75 on 9 October 2026, and the $99.36 consensus target implies upside of about 18.6%.
● The consensus draws on 16 ratings, with targets from $83 to $127, though named targets since July average nearer $91.
● Market data shows no Buy, 12 Hold and four Sell ratings, a Reduce consensus, while the second data set shows Hold.
● Wells Fargo cut to $85 from $90 on 5 October, and TD Cowen cut to $85 from $90 on 30 September.
The Clorox Company (NYSE:CLX), a member of the S&P 500, closed at $83.75 on Friday 9 October 2026. The household products group has attracted a cautious analyst community, with several brokers trimming forecasts.
What Is the Latest Analyst Price Target?
According to market data, the consensus 12-month price target for Clorox is $99.36, based on 16 ratings over the past year. That is about 18.6% above the $83.75 close. The range is wide, from a low of $83 to a high of $127. A second source, the second data set, which draws on third-party data, shows a similar average of $99.59 and a median of $98, but a broader range of $74 to $154 across 18 analysts.
The averages appear to be lifted by a handful of older, higher targets. The named broker targets published since July, discussed below, cluster mostly between the mid-$70s and $100, with an average nearer $91.
What Are Wall Street Analysts Saying?
Market data records no Buy ratings, 12 Hold ratings and 4 Sell ratings, giving a consensus rating of Reduce. The second data set shows one Strong Buy, 13 Hold, two Sell and two Strong Sell, a consensus of Hold. Recent actions point downwards. On 5 October 2026, Wells Fargo lowered its target from $90 to $85 with an Equal Weight rating, and Goldman Sachs moved its target from $77 to $74, according to the second data set. TD Cowen cut from $90 to $85 on 30 September. Citigroup lowered its target from $100 to $97 on 11 September with a Neutral rating.
Earlier, on 4 August, JPMorgan raised its target from $92 to $95 while keeping an Underweight rating, Barclays reiterated Underweight with an $84 target, Deutsche Bank set $98 and Evercore $99. On 28 July, Jefferies downgraded the shares from Buy to Hold and cut its target from $125 to $98.
What Could Help the Stock Reach the Price Target?
For the shares to move toward the consensus level, sentiment on the consumer staples sector would probably need to improve, or Clorox would need to show that volume and margin trends are recovering. The second data set lists analyst estimates for fiscal 2027 of about $7.6 billion in revenue and adjusted earnings per share of roughly $5.75. If reported results meet or beat such estimates, targets could be revised higher.
What Could Prevent the Stock Reaching the Target?
The recent direction of revisions is the main caution: several brokers have lowered targets within the past fortnight, and the latest named figures sit below the consensus average. Hold and Sell ratings outnumber Buy ratings. The shares also trade only modestly above the lowest target on market data's range of $83, so the spread of opinion is considerable.
What Should Investors Watch Next?
It is also worth watching whether the gap between the consensus mean and recent individual broker targets narrows as older forecasts drop out of the data.
Clorox's Averages Sit Above a Downward-Moving Set of Named Targets
Clorox closed at $83.75 on 9 October 2026, with the $99.36 consensus target about 18.6% higher, but the named targets published since July average nearer $91 and the latest figures sit below the consensus. Hold and Sell ratings outnumber Buy ratings, and the shares trade only modestly above the $83 low target in market data. Analyst estimates for fiscal 2027 of about $7.6 billion in revenue and adjusted earnings per share of roughly $5.75 are the benchmark against which results will be judged.






Please wait processing your request...